Clinical Trial

The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders

Study acronym: DANCEREX-DTx
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 10, 2025 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test a new digital therapeutic solution which combines a holistic, multidimensional rehabilitation program based on dance and music with an innovative motivational system (DANCEREX-DTx) in Chronic Neurological Disorders (Multiple Sclerosis and pre-Mild Cognitive Impairment - MCI/ MCI at risk of Alzheimer's Disease). The main questions it aims to answer are 1\] efficacy of the digital therapeutic solution in terms of adherence, clinical/functional measures, quality of life and surrogate measures; 2\] usability and acceptability of the system. Participants will be randomized (with an allocation ratio of 2:2:1) into the experimental group (DANCEREX - 24 sessions of multidimensional dance-based program integrated with an innovative motivational system), active comparator group (24 sessions of multidimensional dance-based program) and placebo group (24 sessions of educational program). Researchers will compare the experimental group to the other two groups to see if a digital therapeutic solution integrating a multidimensional dance-based program and motivational system is effective in increasing adherence to rehabilitation treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-27.
Status change: Not Yet Recruiting → Recruiting 2025-01-09
Trial Details
NCT Number NCT06112639
Lead Sponsor Fondazione Don Carlo Gnocchi ETS
Collaborators: IRCCS Centro San Giovanni di Dio Fatebenefratelli, University of Milano Bicocca, IRCCS Centro Neurolesi Bonino Pulejo
Conditions Sclerosis, Multiple, Neurocognitive Impairment, Mild, Neurocognitive Dysfunction
Enrollment 192 participants
Start Date 2024-01-31
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-01-10